MannKind Corp (MNKD)
7.09
-0.08
(-1.12%)
USD |
NASDAQ |
Nov 04, 16:00
7.12
+0.03
(+0.42%)
After-Hours: 20:00
MannKind Enterprise Value: 1.930B for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 1.930B |
| November 01, 2024 | 1.952B |
| October 31, 2024 | 1.924B |
| October 30, 2024 | 1.910B |
| October 29, 2024 | 1.869B |
| October 28, 2024 | 1.855B |
| October 25, 2024 | 1.778B |
| October 24, 2024 | 1.751B |
| October 23, 2024 | 1.765B |
| October 22, 2024 | 1.806B |
| October 21, 2024 | 1.800B |
| October 18, 2024 | 1.795B |
| October 17, 2024 | 1.795B |
| October 16, 2024 | 1.831B |
| October 15, 2024 | 1.798B |
| October 14, 2024 | 1.778B |
| October 11, 2024 | 1.762B |
| October 10, 2024 | 1.718B |
| October 09, 2024 | 1.748B |
| October 08, 2024 | 1.756B |
| October 07, 2024 | 1.723B |
| October 04, 2024 | 1.765B |
| October 03, 2024 | 1.745B |
| October 02, 2024 | 1.710B |
| October 01, 2024 | 1.701B |
| Date | Value |
|---|---|
| September 30, 2024 | 1.710B |
| September 27, 2024 | 1.685B |
| September 26, 2024 | 1.704B |
| September 25, 2024 | 1.737B |
| September 24, 2024 | 1.765B |
| September 23, 2024 | 1.773B |
| September 20, 2024 | 1.795B |
| September 19, 2024 | 1.822B |
| September 18, 2024 | 1.811B |
| September 17, 2024 | 1.784B |
| September 16, 2024 | 1.781B |
| September 13, 2024 | 1.704B |
| September 12, 2024 | 1.685B |
| September 11, 2024 | 1.666B |
| September 10, 2024 | 1.635B |
| September 09, 2024 | 1.657B |
| September 06, 2024 | 1.611B |
| September 05, 2024 | 1.638B |
| September 04, 2024 | 1.655B |
| September 03, 2024 | 1.652B |
| August 30, 2024 | 1.701B |
| August 29, 2024 | 1.721B |
| August 28, 2024 | 1.602B |
| August 27, 2024 | 1.459B |
| August 26, 2024 | 1.459B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
248.36M
Minimum
Mar 16 2020
1.952B
Maximum
Nov 01 2024
1.038B
Average
1.129B
Median
Aug 02 2021
Enterprise Value Benchmarks
| Mirum Pharmaceuticals Inc | 1.958B |
| NovaBay Pharmaceuticals Inc | 3.645M |
| Palatin Technologies Inc | 13.74M |
| iBio Inc | 9.837M |
| Theriva Biologics Inc | -12.61M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.014M |
| Revenue (Quarterly) | 72.39M |
| Total Expenses (Quarterly) | 56.30M |
| EPS Diluted (Quarterly) | -0.01 |
| Gross Profit Margin (Quarterly) | 71.85% |
| Profit Margin (Quarterly) | -2.78% |
| Earnings Yield | 0.71% |
| Operating Earnings Yield | 2.13% |
| Normalized Earnings Yield | 1.046 |